March 4
Remove red tape to speed new drugs to market, says research CEO
Read moreThe MRCF is the largest life science investment fund in Australia and New Zealand. We are a unique collaboration between major Australian superannuation funds, the Australian and New Zealand governments, Australian state governments and over 50 leading medical research institutes and research hospitals.
Learn more about who we areUnlocking the potential of N-myristoyltransferase (NMT) to develop precision medicines for a range of diseases including cancer and viral infections
View ProjectDeveloping therapeutics for the treatment of ophthalmic diseases, including adenoviral conjunctivitis
View ProjectDeveloping therapies for respiratory infections in patients with asthma and COPD
View ProjectDeveloping therapies for patients with cardiac rhythm diseases and heart failure using wireless cardiac stimulation
View ProjectA clinical-stage biotechnology company focussed on the development of ocular implants
View ProjectDeveloping novel anti-fibrotic therapies for the treatment of scarring associated with chronic kidney disease
View ProjectDeveloping a novel therapy for the treatment of Meibomian Gland Dysfunction
View ProjectThe Institute for Innovation in Biotechnology (IIB) works in close association with the School of Biological Sciences (SBS) at the University of Auckland, and focuses on industry partnerships to accelerate innovation and develop new models of bioscience enterprise training.
ViewOur vision is to perform world-class medical research that focuses on the molecular basis of health and disease. The specific areas of our research include cancer, molecular bioscience, metabolic and musculoskeletal medicine, infection and immunity.
ViewCommitted to making the discoveries that will relieve the future burden of disease, the newly established Monash Biomedicine Discovery Institute at Monash University brings together more than 120 internationally-renowned research teams. Our researchers are supported by world-class technology and infrastructure, and partner with industry, clinicians and researchers internationally to enhance lives through discovery.
ViewThe MRCF collaboration is innovation in action: We provide a path for taking medical science from conception into the real world.
Our Venture capital model is unique. We don’t simply provide investment, we entrepreneurs to create businesses, run companies and everything necessary to ensure our investments succeed.
Learn moreOncoRes Medical receives $150,000 funding boost from Western Australian Government
Read moreWith health policy top of the political agenda, now’s the time to supercharge Australia’s biotech sector says new MRCF Board member
Read more